Hematopoietic stem cell gene therapy for adenosine deaminase deficient-SCID

被引:23
|
作者
Aiuti, Alessandro [1 ,2 ,3 ]
Brigida, Immacolata [1 ,2 ]
Ferrua, Francesca [1 ,2 ]
Cappelli, Barbara [1 ,2 ]
Chiesa, Robert [1 ,2 ]
Marktel, Sarah [1 ,2 ]
Roncarolo, Maria-Grazia [1 ,2 ,4 ]
机构
[1] Sci Inst HS Raffaele, San Raffaele Telethon Inst Gene Therapy HSR TIGET, I-20132 Milan, Italy
[2] Sci Inst HS Raffaele, Pediat Immunohematol & Bone Marrow Transplant Uni, I-20132 Milan, Italy
[3] Univ Roma Tor Vergata, Rome, Italy
[4] Univ Vita Salute, Milan, Italy
关键词
Gene therapy; Hematopoietic stem cell; Bone marrow; Severe combined immunodeficiency; Retroviral vector; SEVERE COMBINED IMMUNODEFICIENCY; BONE-MARROW-TRANSPLANTATION; INSERTIONAL MUTAGENESIS; CD34(+) CELLS; CORD BLOOD; IMMUNE RECONSTITUTION; LENTIVIRAL VECTORS; MOUSE MODEL; ADA; LYMPHOCYTES;
D O I
10.1007/s12026-009-8107-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Gene therapy is a highly attractive strategy for many types of inherited disorders of the immune system. Adenosine deaminase (ADA) deficient-severe combined immunodeficiency (SCID) has been the target of several clinical trials based on the use of hematopoietic stem/progenitor cells engineered with retroviral vectors. The introduction of a low intensity conditioning regimen has been a crucial factor in achieving stable engrafment of hematopoietic stem cells and therapeutic levels of ADA-expressing cells. Recent studies have demonstrated that gene therapy for ADA-SCID has favorable safety profile and is effective in restoring normal purine metabolism and immune functions. Stem cell gene therapy combined with appropriate conditioning regimens might be extended to other genetic disorders of the hematopoietic system.
引用
收藏
页码:150 / 159
页数:10
相关论文
共 50 条
  • [1] Hematopoietic stem cell gene therapy for adenosine deaminase deficient-SCID
    Alessandro Aiuti
    Immacolata Brigida
    Francesca Ferrua
    Barbara Cappelli
    Robert Chiesa
    Sarah Marktel
    Maria-Grazia Roncarolo
    Immunologic Research, 2009, 44 : 150 - 159
  • [2] Update on gene therapy for adenosine deaminase-deficient severe combined immunodeficiency
    Ferrua, Francesca
    Brigida, Immacolata
    Aiuti, Alessandro
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 10 (06) : 551 - 556
  • [3] In vivo T-cell dynamics during immune reconstitution after hematopoietic stem cell gene therapy in adenosine deaminase severe combined immune deficiency
    Selleri, Silvia
    Brigida, Immacolata
    Casiraghi, Miriam
    Scaramuzza, Samantha
    Cappelli, Barbara
    Cassani, Barbara
    Ferrua, Francesca
    Aker, Memet
    Slavin, Shimon
    Scarselli, Alessia
    Cancrini, Caterina
    Marktel, Sarah
    Roncarolo, Maria Grazia
    Aiuti, Alessandro
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (06) : 1368 - U95
  • [4] Gene Therapy for Adenosine Deaminase Deficiency
    Cappell, Barbara
    Aiuti, Alessandro
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2010, 30 (02) : 249 - +
  • [5] Gene therapy for the treatment of adenosine deaminase-deficient severe combined immune deficiency
    Sokolic, Robert
    Candotti, Fabio
    EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (06): : 477 - 485
  • [6] Hematopoietic Stem Cell Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Leads to Long-Term Immunological Recovery and Metabolic Correction
    Gaspar, H. Bobby
    Cooray, Samantha
    Gilmour, Kimberly C.
    Parsley, Kathryn L.
    Zhang, Fang
    Adams, Stuart
    Bjorkegren, Emma
    Bayford, Jinhua
    Brown, Lucinda
    Davies, E. Graham
    Veys, Paul
    Fairbanks, Lynette
    Bordon, Victoria
    Petropolou, Theoni
    Kinnon, Christine
    Thrasher, Adrian J.
    SCIENCE TRANSLATIONAL MEDICINE, 2011, 3 (97)
  • [7] Genotoxicity of retroviral hematopoietic stem cell gene therapy
    Trobridge, Grant D.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (05) : 581 - 593
  • [8] Hematopoietic Stem Cell Transplantation and Hematopoietic Stem Cell Gene Therapy in X-Linked Adrenoleukodystrophy
    Cartier, Nathalie
    Aubourg, Patrick
    BRAIN PATHOLOGY, 2010, 20 (04) : 857 - 862
  • [9] Gene Therapy for Severe Combined Immunodeficiency due to Adenosine Deaminase Deficiency
    Montiel-Equihua, Claudia A.
    Thrasher, Adrian J.
    Gaspar, H. Bobby
    CURRENT GENE THERAPY, 2012, 12 (01) : 57 - 65
  • [10] Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency
    Hassan, Amel
    Booth, Claire
    Brightwell, Alex
    Allwood, Zoe
    Veys, Paul
    Rao, Kanchan
    Hoenig, Manfred
    Friedrich, Wilhelm
    Gennery, Andrew
    Slatter, Mary
    Bredius, Robbert
    Finocchi, Andrea
    Cancrini, Caterina
    Aiuti, Alessandro
    Porta, Fulvio
    Lanfranchi, Arnalda
    Ridella, Michela
    Steward, Colin
    Filipovich, Alexandra
    Marsh, Rebecca
    Bordon, Victoria
    Al-Muhsen, Saleh
    Al-Mousa, Hamoud
    Alsum, Zobaida
    Al-Dhekri, Hasan
    Al Ghonaium, Abdulaziz
    Speckmann, Carsten
    Fischer, Alain
    Mahlaoui, Nizar
    Nichols, Kim E.
    Grunebaum, Eyal
    Al Zahrani, Daifulah
    Roifman, Chaim M.
    Boelens, Jaap
    Davies, E. Graham
    Cavazzana-Calvo, Marina
    Notarangelo, Luigi
    Gaspar, H. Bobby
    BLOOD, 2012, 120 (17) : 3615 - 3624